R&D in Healthcare

A pioneering approach to research and development enables our Healthcare business to discover new treatments and help patients around the world to live a better life.


Vibrant science across the globe

Patients are at the center of all our research and development efforts. We are committed to innovation in science that will ultimately make a meaningful difference in people’s lives all over the world. Ever since Merck KGaA, Darmstadt, Germany, was founded 350 years ago, we have gained unmatched experience in the discovery, development and manufacturing of medicines.

On top of leveraging our experience and expertise, we also believe that a healthier future deserves a sizable investment. In 2018 our Healthcare business devoted roughly 20% of total sales to R&D activities aimed at discovering and developing new therapies. All of these are integrated in a global organization with four strategically located and highly connected hubs on three continents: Darmstadt, Boston, Beijing and Tokyo.

View our robust R&D pipeline across Immunology, Oncology, and Immuno-Oncology to see what we’re currently working on.

View our R&D pipeline

Latest R&D News

View All News
  1. Press Releases

    Merck KGaA, Darmstadt, Germany, Opens State-of-the-art Research Center for ...

    Merck KGaA, Darmstadt, Germany, officially opened its new Research Center for electronic applications on the campus of its headquarters in Darmstadt, Germany, today. With an investment of € 50 million ...

    2020/09/21

  2. Press Releases

    BAVENCIO Pivotal Phase III JAVELIN Bladder 100 Results Published in The New ...

    Merck KGaA, Darmstadt, Germany, which operates its biopharmaceutical business as EMD Serono, Inc. in the US and Canada, and Pfizer Inc. (NYSE: PFE) today announced the publication of detailed results from the..

    2020/09/18

  3. Press Releases

    FDA Accepts Filing of New Drug Application for Tepotinib for the Treatment ...

    Merck KGaA, Darmstadt, Germany, today announced that the US Food and Drug Administration (FDA) has accepted and granted Priority Review to the new drug application (NDA) for once-daily, orally-dosed tepotinib*

    2020/08/25

Diversity is a source of strength. As centers of excellence, our four global R&D hubs allow the 3,000 professionals of our Healthcare research and development team to leverage different cultures, regional knowledge and broad perspectives.

Luciano Rossetti

Head of Research and Development

Work With Us

Join our R&D team

Are you curious to see how you can contribute to a healthier future? Join our team of scientists and development professionals! You can find all open positions within our Healthcare business in the Careers section.

View recent job offers
Work With Us Work With Us

Partner with us

Partner with our R&D experts to unlock your project’s potential. We believe in mutually beneficial alliances built on transparency and commitment to ambitious, well-defined goals. These can be many and varied. For example, to help bring innovations to market, or to better market commercial products. Whatever your project, we are excited to hear your proposal!

Read more

Innovators wanted! We highly value creativity, initiative and innovation. So, it’s very important to us that we recognize scientists, students and entrepreneurs who exhibit these qualities in outstanding work.

Read more

US/NPR/0517/0230(1)a(1)a 

Redirect

You have accessed https://www.emdgroup.com, but for users from your part of the world, we originally designed the following web presence https://www.merckgroup.com.

Let's go

Share Disclaimer

By sharing this content, you are consenting to share your data to this social media provider. More information are available in our Privacy Statement